Exfoliative dermatitis - Dermatitis Exfoliative
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Red (burning) Skin Syndrome ― Erythema ma fua i le tino atoa o faailoga autu ia o Dermatitis Exfoliative (Exfoliative dermatitis).
References
Erythroderma ose ma'i e seasea ae tuga. E ui o le mafuaaga tonu e masani ona le iloa, e mafai ona faʻaosoina e se faʻamaʻi vailaʻau poʻo se kanesa faʻavae. O se tasi o kanesa masani e feso'ota'i ma le exfoliative dermatitis o le pa'u T-cell lymphoma, lea e ono le fa'aalia ni fa'ailoga mo ni masina pe o'o fo'i i tausaga talu ona amata le ma'i o le pa'u. E masani lava, e manaʻomia le falemaʻi mo suʻesuʻega muamua ma togafitiga. O ma'i e maua i fa'ama'i fa'ama'i e masani lava ona iai se va'aiga lelei mo se taimi umi, e ui o mataupu e aunoa ma se mafua'aga manino e foliga mai e fa'aauau pea ma toe fa'afo'i. Ole fa'asologa o ma'i e feso'ota'i ile kanesa e masani lava ona fa'alagolago ile alualu i luma ole kanesa.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
E masani ona fa'aalia le tele o le mumu ma le pa'u e ufiufi ai le 90% o le tino. O lenei tulaga o se fa'ailoga va'aia o le tele o fa'afitauli fa'alesoifua maloloina e pei o le psoriasis, eczema, po'o se tali i nisi vaila'au.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
O le mafuaʻaga sili ona taatele o le erythroderma o le faʻateleina o se faʻamaʻi o le paʻu, e pei o le psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris poʻo se faʻamaʻi vailaʻau, e pei o le faʻaaogaina o vailaʻau faʻamaʻi. Ole fa'ata'ita'iga muamua e tau fa'ase'e ma e masani ona va'aia ile lymphoma T-cell cutaneous. Talu ai e taua le fa'avasegaina mai le lymphoma sela T pa'u, e faia ai se biopsy.